These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
246 related items for PubMed ID: 12707787
1. [Therapy and risk-stratification in hypertrophic cardiomyopathy--a current survey]. Reith S, Klues HG. Z Kardiol; 2003 Apr; 92(4):283-93. PubMed ID: 12707787 [Abstract] [Full Text] [Related]
2. [On the work by S. Reith and H. G. Klues "Therapy and risk-stratification in hypertrophic cardiomyopathy", Z Kardiol 92: 283-293 (2003)]. Schwab J, Bareiter T, Bär I, Gottwik M. Z Kardiol; 2003 Sep; 92(9):763. PubMed ID: 14508595 [No Abstract] [Full Text] [Related]
12. [Hypertrophic cardiomyopathy in 2013]. Giannakopoulos G, Frangos C. Rev Med Suisse; 2013 Mar 06; 9(376):502, 504-7. PubMed ID: 23534110 [Abstract] [Full Text] [Related]
13. Implantable defibrillators and prevention of sudden death in hypertrophic cardiomyopathy. Maron BJ, Spirito P. J Cardiovasc Electrophysiol; 2008 Oct 06; 19(10):1118-26. PubMed ID: 18384577 [Abstract] [Full Text] [Related]
18. Life expectancy gains and cost-effectiveness of implantable cardioverter/defibrillators for the primary prevention of sudden cardiac death in patients with hypertrophic cardiomyopathy. You JJ, Woo A, Ko DT, Cameron DA, Mihailovic A, Krahn M. Am Heart J; 2007 Nov 06; 154(5):899-907. PubMed ID: 17967596 [Abstract] [Full Text] [Related]
19. Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Will there ever be a randomized trial? Olivotto I, Ommen SR, Maron MS, Cecchi F, Maron BJ. J Am Coll Cardiol; 2007 Aug 28; 50(9):831-4. PubMed ID: 17719467 [Abstract] [Full Text] [Related]